Peter N. Johnson, Pharm.D., BCPPS, FPPAG, FCCM, FASHP
Professor of Pharmacy Practice
Pharmacy Clinical & Admin Sci
Phone (405) 271-2730
Fax (405) 271-6750
Office O'Donoghue Research Bldg; 1122 NE 13th St., Ste. 4415, OKC 73117
Email Peter-Johnson@ouhsc.edu
Summary
- President's Associate Presidential Professor
- Director, PGY2 Pediatric Pharmacy Residency
- Director, Pediatric Pharmacotherapy Degree Option
Publications & Presentations
- 1. Goldstone L W, Johnson P N, Fliehman D, Hayes K, Taylor S, Van Devender E A, Chan R. Supporting resident well-being: Considerations for residency program directors and pharmacy enterprise leadership. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2025
2. Johnson P N, Miller J L, Makoni M. Response: Commentary: Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Frontiers in pediatrics. 2025; 13 : 1571691
3. Johnson P N. Pharmacy practice for therapeutic orphans: Current and future reflections for pediatric pharmacy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 2025
4. Chang E, Harkin M, Miller J L, Walsh C, Neely S, Johnson P N. Evaluating the Efficacy and Safety of Erythromycin for the Treatment of Gastroparesis in Infants and Children. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2025; 30 : 70-77
5. Johnson P N, Miller J L. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG. 2024; 29 : 570-577
Grants
- 1. Evaluation of caffeine dosing regimens and the impact of developmental pharmacokinetics in neonates with apnea of prematurity. Misc Non-Federal. Start Date: 2020. End Date: 2021.
2. Characterization of fentanyl metabolic and renal elimination pathways in children less than two years of age. Misc Non-Federal. Start Date: 2018. End Date: 2020.
3. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
4. Development of a dose-exposure response relationship for detection of opioid tolerance in critically-ill children receiving fentanyl continuous infusions. Misc Non-Federal. Start Date: 2015. End Date: 2017.
5. Comparison of amikacin pharmacokinetics in neonates pre- and post- a dosing protocol change. Misc Non-Federal. Start Date: 2014. End Date: 2015.
Awards and Honors
- 31. Pediatric Pharmacy Advocacy Group. Board of Directors Nominee. Date: 2011.
32. University of Oklahoma College of Medicine, Department of Pediatrics. Department of Pediatrics Teaching Award. Date: 2009.
33. Pediatric Pharmacy Advocacy Group. Spirit of PPAG Award. Date: 2008.
34. University of Kentucky Chandler Medical Center. Pharmacy Resident Extra Mile Award. Date: 2006.
35. University of Kentucky College of Pharmacy. Rho Chi Research Symposium--1st Place Award Winner. Date: 2006.
Education
- 1. Degree: PGY2 Pediatric Pharmacy Residency. Kentucky Children's Hospital and University of Kentucky Chandler Medical Center. Date: 2006.
2. Degree: PGY1 Pharmacy Residency. University of Kentucky Chandler Medical Center. Date: 2005.
3. Degree: PharmD. University of Mississippi School of Pharmacy. Date: 2004.
4. Degree: BS. University of Mississippi School of Pharmacy. Date: 2002.
Administrative Assignments
no results